DUAN Yu-long,FAN Xiang-hui,SHI Zhong-zhou,ZHAO Cheng,DING Chao-peng,XIE Hong-quan,ZHANG Xiao-li.Clinical analysis of X-knife under fractionational stereotactic radiotherapy combine whole brain radioterapy for brain metastases tumor[J].Chinese Journal of Radiological Medicine and Protection,2009,29(3):286-287
Clinical analysis of X-knife under fractionational stereotactic radiotherapy combine whole brain radioterapy for brain metastases tumor
Received:June 13, 2008  
DOI:10.3760/cma.j.issn.0254-5098.2009.03.012
KeyWords:Neoplasm metastais  Brain  \ Stereotactic radiotherapy  \ Whole brain radiotherapy  \ Prognosis
FundProject:
Author NameAffiliation
DUAN Yu-long The Second People Hospital of Pingdingshan, Henan Province, Pingdingshan 467000, China 
FAN Xiang-hui The Second People Hospital of Pingdingshan, Henan Province, Pingdingshan 467000, China 
SHI Zhong-zhou The Second People Hospital of Pingdingshan, Henan Province, Pingdingshan 467000, China 
ZHAO Cheng The Second People Hospital of Pingdingshan, Henan Province, Pingdingshan 467000, China 
DING Chao-peng The Second People Hospital of Pingdingshan, Henan Province, Pingdingshan 467000, China 
XIE Hong-quan The Second People Hospital of Pingdingshan, Henan Province, Pingdingshan 467000, China 
ZHANG Xiao-li The Second People Hospital of Pingdingshan, Henan Province, Pingdingshan 467000, China 
Hits: 3113
Download times: 2026
Abstract::
      Objective To evaluate efficiency of brain metastases tumor using X-knife under farctionational stereotactic radiotherapy (FSRT) combine with whole brain radiotherapy (WBRT).Methods Retrospective comparing 51 patients treated by FSRT plus WBRT (FSRT+WBRT group) with 35 patients treated by WBRT alone (WBRT group) on the effecting rate and survival rate.Results The completeness response rate was 49% and 26% (P<0.05) in FSRT+WBRT and WBRT groups, respectively. The effecting rate was 80% and 71% (P>0.05) in FSRT+WBRT and WBRT groups, respectively. The middle survival time was (11.0±1.5) months and (6.5+0.5) months (P<0.05) in FSRT+WBRT and WBRT groups, respectivley. The 0.5-,1.0- and 1.5-years survival rate was 63% and 41% (P>0.05), 51% and 23% (P>0.05) and 24% and 9% (P<0.05) in FSRT+WBRT and WBRT groups, respectively.Conclusions The method with FSRT plus WBRT in the treatment of brain metastases tumor is safe and relieved focal symptom of patients quickly with lesser injury on normal tissue and the survival time be prolonged,it has better therapeutic effects than WBRT alone for treating brain metastases tumor.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9073198  On-line:0

v
Scan QR Code
&et=3C06DB566315F8DC9C11E1E6BF64A1F9E7CFE961F7B54C174D1B0050034DED4DD651F68D422EC88342D73FBD82714A5D7820558925398C4F25399A1996B78BBD2B8DB5F4B7FD5E8097804411144CC34AFB9B640D8BC069CBD8502AF450A8A2958127354ED06A8D176D253E8021B05E68679C46FBA7256C4099B38E2F88957622C31E05B87BEAC0E7&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=DE12191FBD62783C&aid=2D6445638D180DC26B5CC3F5832E2557&vid=&iid=38B194292C032A66&sid=11CEECA6DA9E4AC5&eid=EBD6B792C9111B87&fileno=20090312&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="DE12191FBD62783C"; var my_aid="2D6445638D180DC26B5CC3F5832E2557";